Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Vaxcyte Inc (NQ: PCVX ) 86.83 -5.85 (-6.31%) Streaming Delayed Price Updated: 4:00 PM EST, Nov 15, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Vaxcyte Inc < Previous 1 2 3 4 5 Next > Vaxcyte Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update February 27, 2023 From Vaxcyte, Inc. Via GlobeNewswire Vaxcyte Announces FDA Clearance of Investigational New Drug Application for VAX-24 for the Prevention of Invasive Pneumococcal Disease in Infants February 21, 2023 From Vaxcyte, Inc. Via GlobeNewswire Vaxcyte to Report Fourth Quarter and Full Year 2022 Financial Results on February 27, 2023 February 16, 2023 From Vaxcyte, Inc. Via GlobeNewswire Expert Ratings for Vaxcyte January 03, 2023 Via Benzinga Why Shares of Vaxcyte Rose 110.7% This Week October 29, 2022 The company released early data for a promising pneumonia vaccine. Via The Motley Fool Earnings Scheduled For February 27, 2023 February 27, 2023 Companies Reporting Before The Bell • Kosmos Energy (NYSE:KOS) is projected to report quarterly earnings at $0.14 per share on revenue of $505.61 million. Via Benzinga Preview: Vaxcyte's Earnings February 24, 2023 Via Benzinga Vaxcyte to Present at the SVB Securities Global Biopharma Conference February 07, 2023 From Vaxcyte, Inc. Via GlobeNewswire Vaxcyte’s VAX-24 Granted FDA Breakthrough Therapy Designation for the Prevention of Invasive Pneumococcal Disease in Adults January 05, 2023 From Vaxcyte, Inc. Via GlobeNewswire This Pneumococcal Vaccine Player Is The Top Pick For 2023 For This Analyst January 03, 2023 Via Benzinga Tesla To $205? Here Are 10 Other Price Target Changes For Tuesday January 03, 2023 Goldman Sachs cut Tesla, Inc. (NASDAQ: TSLA) price target from $235 to $205. Goldman Sachs analyst Mark Delaney maintained a Buy rating on the stock. Tesla shares fell 2.6% to $119.93 in pre-market... Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For December 16, 2022 December 16, 2022 Via Benzinga Vaxcyte Reports Third Quarter 2022 Financial Results and Provides Business Update November 07, 2022 From Vaxcyte, Inc. Via GlobeNewswire Benzinga's Top Ratings Upgrades, Downgrades For December 15, 2022 December 15, 2022 Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For November 17, 2022 November 17, 2022 Upgrades Via Benzinga Vaxcyte to Present at Upcoming Investor Conferences November 03, 2022 From Vaxcyte, Inc. Via GlobeNewswire Why Investors Are Suddenly Excited About Vaxcyte October 31, 2022 Vaxcyte, Inc. is a small cap biotech company that catapulted back to mid-cap land with a stunning 110% surge — and may not be done yet. Via MarketBeat Exposures COVID-19 Vaxcyte Announces Closing of $690 Million Public Offering Including Full Exercise of Underwriters’ Option to Purchase Additional Shares October 28, 2022 From Vaxcyte, Inc. Via GlobeNewswire Wingstop, Harley-Davidson, Rollins And Some Other Big Stocks Moving Higher On Wednesday October 26, 2022 U.S. stocks traded mixed, with the Dow Jones gaining more than 200 points on Wednesday. Here are some big stocks recording gains in today’s session. Via Benzinga Vaxcyte Announces Pricing of $600 Million Public Offering October 26, 2022 From Vaxcyte, Inc. Via GlobeNewswire Why Tricida Shares Dipped Around 95%; Here Are 73 Biggest Movers From Yesterday October 25, 2022 Gainers Applied Genetic Technologies Corporation (NASDAQ: AGTC) climbed 62.4% to close at $0.39. Syncona disclosed that it will acquire Applied Genetic Technologies Corporation. Via Benzinga Avis Budget, Scholastic And Other Big Gainers From Monday October 25, 2022 U.S. stocks closed higher on Monday, with the Dow Jones gaining over 400 points. Here is the list of some big stocks recording gains in the previous session. Via Benzinga Vaxcyte Announces Commencement of Proposed Public Offering of Common Stock and Pre-Funded Warrants October 24, 2022 From Vaxcyte, Inc. Via GlobeNewswire Dow Rises 1.5%; Nasdaq Jumps Over 100 Points October 24, 2022 U.S. stocks traded higher toward the end of trading, with the Dow Jones surging more than 450 points on Monday. Via Benzinga Why Vaxcyte Shares Are Trading Sharply Higher? Here Are 63 Stocks Moving In Monday's Mid-Day Session October 24, 2022 Gainers Vaxcyte, Inc. (NASDAQ: PCVX) shares jumped 65% to $33.96 after the company announced positive topline results from the Phase 1/2 clinical proof-of-concept study evaluating the safety,... Via Benzinga Nasdaq Turns Higher; Applied Genetic Technologies Shares Surge October 24, 2022 U.S. stocks traded mostly higher midway through trading, with the Dow Jones surging more than 300 points on Monday. Via Benzinga Vaxcyte Shares Surge As Its Pneumococcal Vaccine On Par With Pfizer's Shot In Study October 24, 2022 Via Benzinga Why Is Tricida (TCDA) Stock Down 90% Today? October 24, 2022 Tricida (TCDA) stock is falling on Monday following the release of poor results from a Phase 3 chronic kidney disease clinical trial. Via InvestorPlace How Is The Market Feeling About Vaxcyte? October 24, 2022 Vaxcyte's (NASDAQ:PCVX) short percent of float has risen 22.85% since its last report. The company recently reported that it has 2.48 million shares sold short, which is 5.43% of all regular shares... Via Benzinga Why Is Vaxcyte (PCVX) Stock Up 70% Today? October 24, 2022 Vaxcyte (PCVX) stock is rocketing higher on Monday after the vaccine company revealed positive data from a Phase 1/2 clinical trial. Via InvestorPlace < Previous 1 2 3 4 5 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
